Skip to main content

IDWeek 2022 Main banner

Tweets by IDWeek 2022

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

749 Views

Poster Session: Adult Vaccines

114 - Long-term Protection Against Herpes Zoster (HZ) by the Adjuvanted Recombinant Zoster Vaccine (RZV): Interim Efficacy, Immuno and Safety Results at Approximately 10 Years after Initial Vaccination

Thursday, October 20, 2022

12:15 PM – 1:30 PM US ET

Location: Hall B + C

The ePoster content is available to users who are logged in.<br><br>Please click the login button at the top right corner and then come back here to use this button.

Presenting Author(s)

Ana Strezova, MD, MSc

Senior Clinical Research and Development Lead
GSK
Rixensart, Brabant Wallon, Belgium

Co-Author(s)

JD

Javier Diez-Domingo, MD, PhD

FISABIO Fundación para el Fomento Investigación Sanitaria y Biomédica de la Comunitat Valenciana
Valencia, Comunidad Valenciana, Spain
KA

Kamal Al Shawafi, MD

Modis c/o GSK
Wavre, Brabant Wallon, Belgium
JT

Juan Carlos Tinoco, MD

Hospital General de Durango
Durango, Durango, Mexico
MS

Meng Shi, MS

Expert Statistician
GSK
Rockville, Maryland, United States
PP

Paola Pirrotta

Expert Safety Scientist
GSK
Wavre, Brabant Wallon, Belgium
AM

Agnes Mwakingwe-Omari, MD/PhD

GSK
Rockville, Maryland, United States